Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
R&D Inquiry Quote
Contact Us

Apta-Index™: VEGF-Stimulated HUVECs (ID# 232)

Back to Search Results

VEGF-Stimulated HUVECs (ID# 232)

VEGF-Stimulated HUVECs
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Peptide VEGF-Stimulated Human Umbilical Vein Endothelial Cells (HUVECs) Tissue N/A nM (reported value) In vivo mice. N/A If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding. The epitope sequence is LFPLH, from which H may function to induce tumor dormancy through inhibition of angiogenesis. See ASS peptide , which also results in suppression of tumor growth.
See also DRW peptide , which also results in suppression of tumor growth.
NH2-ProValValLeuPheProLeuHis-COOH
8 985.29 g/mole

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Asai et al. "Isolation of a Novel Peptide Homing to Tumor-Derived Neovasculature That Suppresses Tumor Growth." Biological Pharmaceutical Bulletin, 25(2002): 904-906.

Have your aptamer oligo synthesized by one of our AFFILIATES

Community Feedback

Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™